Dr. Luis F. Lara, MD

Dr. Lara practices at West Chester Hospital in West Chester, Ohio, part of UC Health.

Dr. Lara's NPI, 1346207818, was assigned on April 28, 2006. Dr. Lara holds Ohio license 35.075545.

Dr. Lara's primary practice is West Chester Hospital, at 7700 University Drive, West Chester, OH 45069 in Butler County. The practice phone is (513) 298-7701.

Dr. Lara's primary practice is West Chester Hospital in West Chester, Ohio, part of UC Health. Dr. Lara is also affiliated with University of Cincinnati Medical Center. The medical group on file is University of Cincinnati Physicians. Dmand AI also links Dr. Lara to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lara practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Lara's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Lara's licenses on file in 2 states: Ohio and Florida.

CMS data shows 68 Medicare services from Dr. Lara across 4 procedure codes in 2024, for 87 Medicare patients. Medicare paid $9,262 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 87 Medicare patients who saw Dr. Lara in 2024. The largest group is 65 to 74, with 42 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 30% are also on Medicaid. Their average risk score is 2.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lara's median patient age at 57, with 55% women.

In 2024, Dr. Lara wrote 151 Medicare Part D claims for 121 patients. 73% of them were for generic drugs. CMS names the drug for 107 of them, across 3 drugs with 11 or more claims each, at $64,838 in total drug cost. In 2023, CMS named 193 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Lara for performance year 2024, reported as part of a group. Dr. Lara accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 39 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Lara, more than 59% of the clinicians it reports for that procedure.

Dmand AI links 65 papers to Dr. Lara, published from 2010 to 2025. 2020 was the busiest year, with 9. The most frequent topics are Pancreatitis, Islets of Langerhans Transplantation and Pancreatectomy. Dr. Lara has published most often in Pancreas. Dr. Lara's most frequent co-authors are Darwin L. Conwell, MD, Somashekar Gopala Krishna, MD and Georgios I. Papachristou, MD.

Dmand AI links Dr. Lara to 1 clinical trial. Conditions studied include Pancreatitis and Pancreatic Diseases.

CMS Open Payments shows 181 general payments to Dr. Lara from 19 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 84% of the total. Abbvie Inc. paid the most, $147,619.